Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 113   

Articles published

SHP 4,988.04 +2.04 (0.04%)
price chart
Why Are Shire PLC Shares Trading So Far Below The AbbVie Offer Price?
In a footnote to Shire's most recent update, the company says that any firm offer from AbbVie needs to be the greater of �46.26, or the sum of �24.44, plus the value of 0.8960 AbbVie shares at time of the offer.
Shire ready to bow to AbbVie's increased $53 billion offer  Reuters
If AbbVie Succeeds There Could Be a Homecoming for Shire  Wall Street Journal (blog)
Related articles »  
Which Bid Target Should You Buy: Shire PLC Or AstraZeneca plc?
shire It's been an extremely busy year for the healthcare sector, as bids for Shire (LSE: SHP) (NASDAQ: SHPG.US) and AstraZeneca (LSE: AZN) (NYSE: AZN.
Related articles »  
The AbbVie Inc, Shire PLC, Merger Will Not Change The US Tax On US Profits
We hear this morning that AbbVie AbbVie has been successful in bidding for Shire Shire and that the newly merged company will arise, as a butterfly from a chrysalis, as a UK domiciled company.
AbbVie's $55 Billion Deal To Buy Shire Is Worth it  Barron's
AbbVie deal allows it to lower tax bill  Taipei Times
Related articles »  
Form 8.3 - SHIRE PLC
Form 8.3 - SHIRE PLC. July 25, 2014 10:58 AM Eastern Daylight Time. LONDON--(BUSINESS WIRE)--. FORM 8.3. PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY.
Related articles »  
AbbVie Will Make Another Attempt To Buy Shire PLC
Indeed, it is now widely believed that the US pharmaceutical giant will return to make another bid for Shire. City analysts believe the AbbVie could offer as much as �62.00 per share for Shire, a 34% premium to the previous offer of �46.26 per share.
Related articles »  
Why AbbVie Inc Is Buying Shire PLC
The rise of Shire (LSE: SHP) has largely been unnoticed. I had always assumed it was a small cap, but did you know it has a market capitalisation (�30 billion) equivalent to BT or Standard Chartered?
Shire's Executives To Receive 100-200% Of Annual Pay For Staying  Bidness Etc
Abbvie's $8 billion in tax breaks from Shire deal may come just in time  MarketWatch (blog)
Related articles »  
Shire PLC Given �Market Perform� Rating at Sanford C. Bernstein (SHP)
Shire PLC logo Shire PLC (LON:SHP)'s stock had its �market perform� rating reiterated by Sanford C. Bernstein in a research note issued on Friday.
Poundland Group PLC Now Covered by Analysts at Jefferies Group (PLND)  Watch List News (press release)
Croda International Plc PT Lowered to GBX 2300 (CRDA)  Intercooler
Related articles »  
3 Reasons Why You Should Sell Shire PLC
Shire (LSE: SHP) (NASDAQOTH: SHPG.US) shareholders have seen the value of their stock rise by 60% this year, thanks mainly to a takeover bid from US firm AbbVie.
Related articles »  
Shire plc (SHPG) Enters Licensing Agreement for AGT-182
Shire plc (Nasdaq: SHPG) announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy (ERT) for the potential treatment of both the central nervous system (CNS) and somatic manifestations in ...
Shire plc: Shire Enters Strategic Licensing and Collaboration Agreement with ...  The Wall Street Transcript
Shire In $225 Mln Licensing, Collaboration Deal With ArmaGen For AGT-182  NASDAQ
Related articles »  
Is Hikma Pharmaceuticals Plc A Better Buy Than GlaxoSmithKline plc Or Shire ...
shire It's been a great first half of 2014 for investors in Hikma (LSE: HIK), with the pharmaceutical company seeing its share price rise by 47%, while the FTSE 100 is up just 1.5%.